Raia Drogasil S.A. ("Raia Drogasil") i n accordance with the CVM Instruction No. 358/02, as amended, hereby announces to the public the new store openings guideline for the exercise of 2020, expected at 240 gross openings.
The guidelines were elaborated based on our past experience and consider our expectations regarding our operations, observing, especially:
our expansion strategy;
our financial capacity to support investments;
our capacity to obtain attractive locations at sound expected returns;
our capacity to implement new stores, including our engineering structure and qualified personnel availability within our career plan in order to operate those stores;
other circumstances inherent to the expansion activities.
It is important to mention that this guidance are estimates, and does not constitute a performance promise, and that they may be reviewed (positively or negatively) by the Company's management.
São Paulo, October 3, 2019.
Eugenio De Zagottis
Investor Relations Officer
SP - 14316992v4
Attachments
Original document
Permalink
Disclaimer
Raia Drogasil SA published this content on 03 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2019 02:01:07 UTC
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
RAIA DROGASIL S.A. 
